Turtle Creek Wealth Advisors LLC increased its holdings in Cigna Group (NYSE:CI – Free Report) by 15.7% in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 21,445 shares of the health services provider’s stock after acquiring an additional 2,905 shares during the quarter. Turtle Creek Wealth Advisors LLC’s holdings in Cigna Group were worth $6,182,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other hedge funds have also added to or reduced their stakes in the stock. Wilsey Asset Management Inc. lifted its stake in shares of Cigna Group by 2.9% in the 2nd quarter. Wilsey Asset Management Inc. now owns 101,936 shares of the health services provider’s stock valued at $33,698,000 after purchasing an additional 2,847 shares during the period. SCS Capital Management LLC raised its holdings in Cigna Group by 39.1% in the second quarter. SCS Capital Management LLC now owns 30,633 shares of the health services provider’s stock worth $10,127,000 after purchasing an additional 8,609 shares in the last quarter. Retirement Systems of Alabama lifted its position in Cigna Group by 3.9% during the second quarter. Retirement Systems of Alabama now owns 165,487 shares of the health services provider’s stock valued at $54,707,000 after buying an additional 6,155 shares during the period. Janney Montgomery Scott LLC boosted its holdings in shares of Cigna Group by 3.9% during the 2nd quarter. Janney Montgomery Scott LLC now owns 35,943 shares of the health services provider’s stock valued at $11,882,000 after buying an additional 1,357 shares in the last quarter. Finally, Natixis grew its position in shares of Cigna Group by 69.5% in the 2nd quarter. Natixis now owns 223,884 shares of the health services provider’s stock worth $74,012,000 after buying an additional 91,794 shares during the period. 86.99% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, CEO David Cordani purchased 4,134 shares of the company’s stock in a transaction dated Monday, November 3rd. The shares were purchased at an average price of $241.88 per share, with a total value of $999,931.92. Following the acquisition, the chief executive officer directly owned 157,935 shares in the company, valued at $38,201,317.80. The trade was a 2.69% increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.70% of the stock is currently owned by insiders.
Cigna Group Stock Performance
Cigna Group (NYSE:CI – Get Free Report) last posted its earnings results on Thursday, October 30th. The health services provider reported $7.83 EPS for the quarter, topping analysts’ consensus estimates of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The business had revenue of $69.57 billion during the quarter, compared to analyst estimates of $66.40 billion. During the same quarter last year, the company earned $7.51 EPS. The company’s quarterly revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. As a group, research analysts forecast that Cigna Group will post 29.77 earnings per share for the current fiscal year.
Cigna Group Dividend Announcement
The business also recently announced a quarterly dividend, which was paid on Thursday, December 18th. Shareholders of record on Thursday, December 4th were paid a dividend of $1.51 per share. The ex-dividend date was Thursday, December 4th. This represents a $6.04 annualized dividend and a yield of 2.2%. Cigna Group’s dividend payout ratio is currently 26.64%.
Analyst Ratings Changes
Several equities research analysts recently commented on CI shares. Weiss Ratings reissued a “hold (c-)” rating on shares of Cigna Group in a research note on Monday, December 29th. Truist Financial boosted their price target on Cigna Group from $310.00 to $320.00 and gave the stock a “buy” rating in a research report on Monday, January 5th. Wolfe Research cut their price target on Cigna Group from $345.00 to $325.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 15th. TD Cowen lowered their price objective on Cigna Group from $387.00 to $333.00 and set a “buy” rating for the company in a research note on Tuesday, November 4th. Finally, Robert W. Baird cut their target price on Cigna Group from $372.00 to $315.00 and set an “outperform” rating on the stock in a research note on Thursday, December 11th. One research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and four have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $330.48.
Check Out Our Latest Research Report on Cigna Group
Cigna Group Profile
Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.
In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.
See Also
- Five stocks we like better than Cigna Group
- Wall Street Alert: Buy AES
- Refund From 1933: Trump’s Reset May Create Instant Wealth
- Trump’s AI Secret: 100X Faster Than Nvidia
- A U.S. “birthright” claim worth trillions – activated quietly
- Trump Did WHAT??
Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI – Free Report).
Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.
